Search Results - "Yanagimoto, Hiroaki"

Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study by UENO, Hideki, IOKA, Tatsuya, SHIMAMURA, Tomotaka, SHO, Masayuki, KITANO, Masayuki, CHENG, Ann-Lii, MIZUMOTO, Kazuhiro, CHEN, Jen-Shi, FURUSE, Junji, FUNAKOSHI, Akihiro, HATORI, Takashi, YAMAGUCHI, Taketo, IKEDA, Masafumi, EGAWA, Shinichi, SATO, Atsushi, OHASHI, Yasuo, OKUSAKA, Takuji, TANAKA, Masao, OHKAWA, Shinichi, YANAGIMOTO, Hiroaki, BOKU, Narikazu, FUKUTOMI, Akira, SUGIMORI, Kazuya, BABA, Hideo, YAMAO, Kenji

“…The present phase III study was designed to investigate the noninferiority of S-1 alone and superiority of gemcitabine plus S-1 compared with gemcitabine alone…”
Get full text

Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study by Hijioka, Susumu, Hosoda, Waki, Matsuo, Keitaro, Ueno, Makoto, Furukawa, Masayuki, Yoshitomi, Hideyuki, Kobayashi, Noritoshi, Ikeda, Masafumi, Ito, Tetsuhide, Nakamori, Shoji, Ishii, Hiroshi, Kodama, Yuzo, Morizane, Chigusa, Okusaka, Takuji, Yanagimoto, Hiroaki, Notohara, Kenji, Taguchi, Hiroki, Kitano, Masayuki, Yane, Kei, Maguchi, Hiroyuki, Tsuchiya, Yoshiaki, Komoto, Izumi, Tanaka, Hiroki, Tsuji, Akihito, Hashigo, Syunpei, Kawaguchi, Yoshiaki, Mine, Tetsuya, Kanno, Atsushi, Murohisa, Go, Miyabe, Katsuyuki, Takagi, Tadayuki, Matayoshi, Nobutaka, Yoshida, Tsukasa, Hara, Kazuo, Imamura, Masayuki, Furuse, Junji, Yatabe, Yasushi, Mizuno, Nobumasa

“…Patients with pancreatic neuroendocrine neoplasm grade-3 (PanNEN-G3) show variable responses to platinum-based chemotherapy. Recent studies indicated that…”
Get full text

Clinical benefits of neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreatic head: an observational study using inverse probability of treatment weighting by Fujii, Tsutomu, Satoi, Sohei, Yamada, Suguru, Murotani, Kenta, Yanagimoto, Hiroaki, Takami, Hideki, Yamamoto, Tomohisa, Kanda, Mitsuro, Yamaki, So, Hirooka, Satoshi, Kon, Masanori, Kodera, Yasuhiro

“…Background The efficacy of neoadjuvant chemoradiotherapy (NACRT) and subset of pancreatic ductal adenocarcinoma (PDAC) patients who are most likely to benefit…”
Get full text

Glucose Tolerance after Pancreatectomy: A Prospective Observational Follow-Up Study of Pancreaticoduodenectomy and Distal Pancreatectomy by Ishida, Jun, Toyama, Hirochika, Matsumoto, Ippei, Shirakawa, Sachiyo, Terai, Sachio, Yamashita, Hironori, Yanagimoto, Hiroaki, Asari, Sadaki, Kido, Masahiro, Fukumoto, Takumi

“…Effects of pancreatectomy on glucose tolerance have not been clarified, and evidence regarding the difference in postoperative glucose tolerance between…”
Get full text

PD-L1 expression in pancreatic ductal adenocarcinoma is a poor prognostic factor in patients with high CD8+ tumor-infiltrating lymphocytes: highly sensitive detection using phosphor-integrated dot staining by Yamaki, So, Yanagimoto, Hiroaki, Tsuta, Koji, Ryota, Hironori, Kon, Masanori

“…Background Pancreatic ductal adenocarcinoma (PDAC) has an extremely poor prognosis. For the development of more effective immunotherapies, it is first…”
Get full text

Impact of Hepatectomy for Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombus by Komatsu, Shohei, Kido, Masahiro, Kuramitsu, Kaori, Tsugawa, Daisuke, Gon, Hidetoshi, Fukushima, Kenji, Urade, Takeshi, Yanagimoto, Hiroaki, Toyama, Hirochika, Fukumoto, Takumi

“…Background Optimal treatment strategies for advanced hepatocellular carcinoma (HCC) with macroscopic portal vein tumor thrombus (PVTT) remain controversial…”
Get full text

Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patients by Aoki, Shuichi, Motoi, Fuyuhiko, Murakami, Yoshiaki, Sho, Masayuki, Satoi, Sohei, Honda, Goro, Uemura, Kenichiro, Okada, Ken-Ichi, Matsumoto, Ippei, Nagai, Minako, Yanagimoto, Hiroaki, Kurata, Masanao, Fukumoto, Takumi, Mizuma, Masamichi, Yamaue, Hiroki, Unno, Michiaki

“…Carbohydrate antigen (CA) 19-9 levels after resection are considered to predict prognosis; however, the significance of decreased CA19-9 levels after…”
Get full text

Hepatectomy versus sorafenib for advanced hepatocellular carcinoma with macroscopic portal vein tumor thrombus: A bi‐institutional propensity‐matched cohort study by Komatsu, Shohei, Ueshima, Kazuomi, Kido, Masahiro, Kuramitsu, Kaori, Tsugawa, Daisuke, Yanagimoto, Hiroaki, Toyama, Hirochika, Ku, Yonon, Kudo, Masatoshi, Fukumoto, Takumi

“…Aim Sorafenib was previously considered a first‐line treatment for hepatocellular carcinoma (HCC) patients with macroscopic portal vein tumor thrombus (PVTT)…”
Get full text

Massive digital gene expression analysis reveals different predictive profiles for immune checkpoint inhibitor therapy between adenocarcinoma and squamous cell carcinoma of advanced lung cancer by Kaneda, Toshihiko, Kurata, Takayasu, Yoshida, Tomoko, Kibata, Kayoko, Yoshioka, Hiroshige, Yanagimoto, Hiroaki, Takeda, Kazuhiko, Yoshida, Takao, Tsuta, Koji

“…Immune checkpoint inhibitors prolong the survival of non-small cell lung cancer (NSCLC) patients. Although it has been acknowledged that there is some…”
Get full text

Increased expression of SPRR1A is associated with a poor prognosis in pancreatic ductal adenocarcinoma by Yamakawa, Kohei, Koyanagi-Aoi, Michiyo, Uehara, Keiichiro, Masuda, Atsuhiro, Yanagimoto, Hiroaki, Toyama, Hirochika, Fukumoto, Takumi, Kodama, Yuzo, Aoi, Takashi

“…Small proline-rich protein 1A (SPRR1A) is recognized as a squamous differentiation marker but is also upregulated in some non-squamous cancers. However, its…”
Get full text

Impact of Preoperative Biliary Drainage on Long-Term Survival in Resected Pancreatic Ductal Adenocarcinoma: A Multicenter Observational Study by Uemura, Kenichiro, Murakami, Yoshiaki, Satoi, Sohei, Sho, Masayuki, Motoi, Fuyuhiko, Kawai, Manabu, Matsumoto, Ippei, Honda, Goro, Kurata, Masanao, Yanagimoto, Hiroaki, Nishiwada, Satoshi, Fukumoto, Takumi, Unno, Michiakil, Yamaue, Hiroki

“…Background This study aimed to evaluate the impact of preoperative biliary drainage (PBD) on the long-term survival of patients with pancreatic ductal…”
Get full text

Antibiotic prophylaxis in laparoscopic cholecystectomy: a randomized controlled trial by Matsui, Yoichi, Satoi, Sohei, Kaibori, Masaki, Toyokawa, Hideyoshi, Yanagimoto, Hiroaki, Matsui, Kosuke, Ishizaki, Morihiko, Kwon, A-Hon

“…Recent meta-analyses concluded that antibiotic prophylaxis is not warranted in low-risk laparoscopic cholecystectomy. However, most trials in the meta-analyses…”
Get full text

National Comprehensive Cancer Network Resectability Status for Pancreatic Carcinoma Predicts Overall Survival by Murakami, Yoshiaki, Satoi, Sohei, Sho, Masayuki, Motoi, Fuyuhiko, Matsumoto, Ippei, Kawai, Manabu, Honda, Goro, Uemura, Kenichiro, Yanagimoto, Hiroaki, Shinzeki, Makoto, Kurata, Masanao, Kinoshita, Shoichi, Yamaue, Hiroki, Unno, Michiaki

“…Background The aim of this study was to evaluate the validity of preoperative resectability status, as defined by the National Comprehensive Cancer Network…”
Get full text

Randomized phase II study of chemoradiotherapy with versus without induction chemotherapy for locally advanced pancreatic cancer: Japan Clinical Oncology Group trial, JCOG1106 by Ioka, Tatsuya, Furuse, Junji, Fukutomi, Akira, Mizusawa, Junki, Nakamura, Satoaki, Hiraoka, Nobuyoshi, Ito, Yoshinori, Katayama, Hiroshi, Ueno, Makoto, Ikeda, Masafumi, Sugimori, Kazuya, Okano, Naohiro, Shimizu, Kyoko, Yanagimoto, Hiroaki, Okusaka, Takuji, Ozaka, Masato, Todaka, Akiko, Nakamori, Shoji, Tobimatsu, Kazutoshi, Sata, Naohiro, Kawashima, Yohei, Hosokawa, Ayumu, Yamaguchi, Taketo, Miyakawa, Hiroyuki, Hara, Hiroki, Mizuno, Nobumasa, Ishii, Hiroshi

“…Abstract Background Chemoradiotherapy is a treatment option for locally advanced pancreatic cancer. However, the efficacy of induction chemotherapy prior to…”
Get full text

Prognosis after surgical treatment for pancreatic cancer in patients aged 80 years or older: a multicenter study by Sho, Masayuki, Murakami, Yoshiaki, Kawai, Manabu, Motoi, Fuyuhiko, Satoi, Sohei, Matsumoto, Ippei, Honda, Goro, Uemura, Kenichiro, Yanagimoto, Hiroaki, Kurata, Masanao, Akahori, Takahiro, Kinoshita, Shoichi, Nagai, Minako, Nishiwada, Satoshi, Fukumoto, Takumi, Unno, Michiaki, Yamaue, Hiroki, Nakajima, Yoshiyuki

“…Background The optimal therapeutic strategy for very elderly pancreatic cancer patients remains to be determined. The aim of this study was to clarify the role…”
Get full text

Risk factors for latent distant organ metastasis detected by staging laparoscopy in patients with radiologically defined locally advanced pancreatic ductal adenocarcinoma by Karabicak, Ilhan, Satoi, Sohei, Yanagimoto, Hiroaki, Yamamoto, Tomohisa, Hirooka, Satoshi, Yamaki, So, Kosaka, Hisashi, Inoue, Kentaro, Matsui, Yoichi, Kon, Masanori

“…Objectives We aimed to identify risk factors for latent distant organ metastasis in patients with radiographically defined locally advanced (RDLA) pancreatic…”
Get full text

Use of a short cartridge stapler is beneficial in pancreatic transection at the neck during laparoscopic distal pancreatectomy by Ishida, Jun, Toyama, Hirochika, Asari, Sadaki, Goto, Tadahiro, Nanno, Yoshihide, Mizumoto, Takuya, Tsugawa, Daisuke, Komatsu, Shohei, Kuramitsu, Kaori, Yanagimoto, Hiroaki, Kido, Masahiro, Fukumoto, Takumi

“…Stapling is the standard method for pancreatic transection during laparoscopic distal pancreatectomy. Although most surgeons use a 60 mm cartridge stapler,…”
Get full text

Space-Making Particle Therapy for Unresectable Hilar Cholangiocarcinoma by Hashimoto, Yu, Komatsu, Shohei, Terashima, Kazuki, Tsugawa, Daisuke, Yanagimoto, Hiroaki, Suga, Masaki, Demizu, Yusuke, Tokumaru, Sunao, Okimoto, Tomoaki, Sasaki, Ryohei, Ajiki, Tetsuo, Fukumoto, Takumi

“…Although the primary treatment option for hilar cholangiocarcinoma (HC) has been surgical resection, most patients present with unresectable advanced tumors at…”
Get more information

Benefits of Conversion Surgery after Multimodal Treatment for Unresectable Pancreatic Ductal Adenocarcinoma by Yanagimoto, Hiroaki, Satoi, Sohei, Yamamoto, Tomohisa, Yamaki, So, Hirooka, Satoshi, Kotsuka, Masaya, Ryota, Hironori, Ishida, Mitsuaki, Matsui, Yoichi, Sekimoto, Mitsugu

“…Background: Traditionally, the treatment options for unresectable locally advanced (UR-LA) and metastatic (UR-M) pancreatic ductal adenocarcinoma (PDAC) are…”
Get full text

Advantage of endoscopic papillectomy for ampullary tumors as an alternative treatment for pancreatoduodenectomy by Abe, Shohei, Sakai, Arata, Masuda, Atsuhiro, Miki, Mika, Harada, Yoshiyuki, Nagao, Kae, Inomata, Noriko, Kohashi, Shinya, Uemura, Hisahiro, Masuda, Shigeto, Ashina, Shigeto, Gonda, Masanori, Yamakawa, Kohei, Tsujimae, Masahiro, Yamada, Yasutaka, Tanaka, Takeshi, Kobayashi, Takashi, Nakano, Ryota, Shiomi, Hideyuki, Tsugawa, Daisuke, Yanagimoto, Hiroaki, Ajiki, Tetsuo, Kanzawa, Maki, Fukumoto, Takumi, Itoh, Tomoo, Kodama, Yuzo

“…Endoscopic papillectomy for early ampullary tumors is considered a minimally invasive and useful alternative to pancreatoduodenectomy; however, its indications…”
Get full text